Assessing Approvals and Costs of Classical Hematology Drugs
A recent analysis examining U.S. trends in approvals and costs of classical hematology drugs shows that an estimated 2024 U.S. gross sales in this...
Study Sets Threshold for Cost-Effective Iron-Deficiency Screening
A new study shows that identifying and treating iron deficiency during the second trimester of pregnancy is cost-effective at a threshold of <30 μg/L...
Graded Mobility Better at Predicting VTE
New research shows that each measurable drop in mobility during a hospital stay increases the risk of venous thromboembolism (VTE). The results support the...
APP-Led Program Lessens Time to Diagnosis and Access to Care
A lymphoma program led by advanced practice providers (APPs) effectively reduced time to diagnosis and access to care, according to new research.
“Lymphoma consists of...